Emerging studies suggest Retatrutide , a dual agonist targeting both the gut-brain axis and GIP , may represent a significant step forward for weight loss . Early patient tests have indicated https://bookmarksbay.com/story21481719/the-retatrutide-peptide-peptide-a-breakthrough-in-weight-regulation